Catalio-Capital-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ASND",
  "INSP",
  "VCYT",
  "MGX",
  "SWTX",
  "LIVN",
  "ADPT",
  "GPCR",
  "REPL",
  "SNDX",
  "KROS",
  "ATAI",
  "FULC",
  "GUTS",
  "ISRG",
  "KYTX",
  "MRSN",
  null,
  "SNSE",
  "SEPN",
  "ZBIO",
  "TARA",
  null,
  "REGN",
  null,
  "MLTX",
  "SLNO",
  "QURE",
  "EW",
  "HYPR",
  "KPTI",
  "VIR",
  "BDX",
  "BBIO",
  "CYTK",
  "DNTH",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 37
Total Value: 411104315
Accession Number: 0001958125-25-000004
Form Type: 13F-HR
CIK: catalio-capital-management-lp
Manager Name: Catalio-Capital-Management-Lp

Data Enrichment

92% identified

34 identified3 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

37 positions • $411.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

Adaptive Biotechnologies Corp

ADPT|00650F109

Shares:611.6K

Value:$4.5M

% of Portfolio:1.1% ($4.5M/$411.1M)

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:114.6K

Value:$4.5M

% of Portfolio:1.1% ($4.5M/$411.1M)

Keros Therapeutics, Inc.

KROS|492327101

Shares:389.4K

Value:$4.0M

% of Portfolio:1.0% ($4.0M/$411.1M)

Vir Biotechnology, Inc.

VIR|92764N102

Shares:611.6K

Value:$4.0M

% of Portfolio:1.0% ($4.0M/$411.1M)

Replimune Group, Inc.

REPL|76029N106

Shares:355.6K

Value:$3.5M

% of Portfolio:0.8% ($3.5M/$411.1M)

Zenas BioPharma, Inc.

ZBIO|98937L105

Shares:295.1K

Value:$2.3M

% of Portfolio:0.6% ($2.3M/$411.1M)

690145206

Shares:166.7K

Value:$1.8M

% of Portfolio:0.4% ($1.8M/$411.1M)

03969K958

Shares:100.0K

Value:$1.3M

% of Portfolio:0.3% ($1.3M/$411.1M)

Kyverna Therapeutics, Inc.

KYTX|501976104

Shares:586.9K

Value:$1.1M

% of Portfolio:0.3% ($1.1M/$411.1M)

Metagenomi, Inc.

MGX|59102M104

Shares:529.0K

Value:$719.4K

% of Portfolio:0.2% ($719.4K/$411.1M)

Mersana Therapeutics, Inc.

MRSN|59045L106

Shares:1.7M

Value:$586.9K

% of Portfolio:0.1% ($586.9K/$411.1M)

Fulcrum Therapeutics, Inc.

FULC|359616109

Shares:202.1K

Value:$582.2K

% of Portfolio:0.1% ($582.2K/$411.1M)

Karyopharm Therapeutics Inc.

KPTI|48576U205

Shares:155.6K

Value:$582.0K

% of Portfolio:0.1% ($582.0K/$411.1M)

Hyperfine, Inc.

HYPR|44916K106

Shares:760.0K

Value:$544.4K

% of Portfolio:0.1% ($544.4K/$411.1M)

ATAI Life Sciences N.V.

ATAI|N0731H103

Shares:196.9K

Value:$267.7K

% of Portfolio:0.1% ($267.7K/$411.1M)

FRACTYL HEALTH, INC.

GUTS|35168W103

Shares:214.2K

Value:$254.9K

% of Portfolio:0.1% ($254.9K/$411.1M)

Sensei Biotherapeutics, Inc.

SNSE|81728A108

Shares:294.4K

Value:$116.0K

% of Portfolio:0.0% ($116.0K/$411.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Adaptive Biotechnologies Corp(ADPTcusip00650F109)	611.6K	QoQ NEW(+611.6K) YoY-	All Managers (Combined)	$4.5M	1.1% ($4.5M/$411.1M)	QoQ NEW(+$4.5M) YoY-
MoonLake Immunotherapeutics(MLTXcusip61559X104)	114.6K	QoQ NEW(+114.6K) YoY-	All Managers (Combined)	$4.5M	1.1% ($4.5M/$411.1M)	QoQ NEW(+$4.5M) YoY-
Keros Therapeutics, Inc.(KROScusip492327101)	389.4K	QoQ -4.39% (-17.9K) YoY-	All Managers (Combined)	$4.0M	1.0% ($4.0M/$411.1M)	QoQ -38.45% (-$2.5M) YoY-
Vir Biotechnology, Inc.(VIRcusip92764N102)	611.6K	QoQ NEW(+611.6K) YoY-	All Managers (Combined)	$4.0M	1.0% ($4.0M/$411.1M)	QoQ NEW(+$4.0M) YoY-
Replimune Group, Inc.(REPLcusip76029N106)	355.6K	QoQ NEW(+355.6K) YoY-	All Managers (Combined)	$3.5M	0.8% ($3.5M/$411.1M)	QoQ NEW(+$3.5M) YoY-
Zenas BioPharma, Inc.(ZBIOcusip98937L105)	295.1K	QoQ +57.67% (+108.0K) YoY-	All Managers (Combined)	$2.3M	0.6% ($2.3M/$411.1M)	QoQ +52.09% (+$798.6K) YoY-
(cusip690145206)✕	166.7K	QoQ NEW(+166.7K) YoY-	All Managers (Combined)	$1.8M	0.4% ($1.8M/$411.1M)	QoQ NEW(+$1.8M) YoY-
(cusip03969K958)✕	100.0K	QoQ NEW(+100.0K) YoY-	All Managers (Combined)	$1.3M	0.3% ($1.3M/$411.1M)	QoQ NEW(+$1.3M) YoY-
Kyverna Therapeutics, Inc.(KYTXcusip501976104)	586.9K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.1M	0.3% ($1.1M/$411.1M)	QoQ -48.39% (-$1.1M) YoY-
Metagenomi, Inc.(MGXcusip59102M104)	529.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$719.4K	0.2% ($719.4K/$411.1M)	QoQ -62.32% (-$1.2M) YoY-
Mersana Therapeutics, Inc.(MRSNcusip59045L106)	1.7M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$586.9K	0.1% ($586.9K/$411.1M)	QoQ -75.93% (-$1.9M) YoY-
Fulcrum Therapeutics, Inc.(FULCcusip359616109)	202.1K	QoQ NEW(+202.1K) YoY-	All Managers (Combined)	$582.2K	0.1% ($582.2K/$411.1M)	QoQ NEW(+$582.2K) YoY-
Karyopharm Therapeutics Inc.(KPTIcusip48576U205)	155.6K	QoQ NEW(+155.6K) YoY-	All Managers (Combined)	$582.0K	0.1% ($582.0K/$411.1M)	QoQ NEW(+$582.0K) YoY-
Hyperfine, Inc.(HYPRcusip44916K106)	760.0K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$544.4K	0.1% ($544.4K/$411.1M)	QoQ -18.60% (-$124.4K) YoY-
ATAI Life Sciences N.V.(ATAIcusipN0731H103)	196.9K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$267.7K	0.1% ($267.7K/$411.1M)	QoQ +2.25% (+$5.9K) YoY-
FRACTYL HEALTH, INC.(GUTScusip35168W103)	214.2K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$254.9K	0.1% ($254.9K/$411.1M)	QoQ -42.23% (-$186.4K) YoY-
Sensei Biotherapeutics, Inc.(SNSEcusip81728A108)	294.4K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$116.0K	0.0% ($116.0K/$411.1M)	QoQ -19.60% (-$28.3K) YoY-